379 related articles for article (PubMed ID: 28915889)
21. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.
Chaudhary NI; Roth GJ; Hilberg F; Müller-Quernheim J; Prasse A; Zissel G; Schnapp A; Park JE
Eur Respir J; 2007 May; 29(5):976-85. PubMed ID: 17301095
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
[TBL] [Abstract][Full Text] [Related]
23. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
[TBL] [Abstract][Full Text] [Related]
24. Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity.
Cutolo M; Gotelli E; Montagna P; Tardito S; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S
Arthritis Res Ther; 2021 Aug; 23(1):205. PubMed ID: 34344444
[TBL] [Abstract][Full Text] [Related]
25. TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation.
Pilling D; Vakil V; Cox N; Gomer RH
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11929-34. PubMed ID: 26351669
[TBL] [Abstract][Full Text] [Related]
26. R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation.
Chiang HY; Chu PH; Lee TH
PLoS One; 2017; 12(10):e0185811. PubMed ID: 28968441
[TBL] [Abstract][Full Text] [Related]
27. Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease.
Atanelishvili I; Akter T; Noguchi A; Vuyiv O; Wollin L; Silver RM; Bogatkevich GS
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):115-124. PubMed ID: 31573469
[TBL] [Abstract][Full Text] [Related]
28. Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator.
De Ruysscher D; Granton PV; Lieuwes NG; van Hoof S; Wollin L; Weynand B; Dingemans AM; Verhaegen F; Dubois L
Radiother Oncol; 2017 Sep; 124(3):482-487. PubMed ID: 28774597
[TBL] [Abstract][Full Text] [Related]
29. Effects of nintedanib on the microvascular architecture in a lung fibrosis model.
Ackermann M; Kim YO; Wagner WL; Schuppan D; Valenzuela CD; Mentzer SJ; Kreuz S; Stiller D; Wollin L; Konerding MA
Angiogenesis; 2017 Aug; 20(3):359-372. PubMed ID: 28283856
[TBL] [Abstract][Full Text] [Related]
30. Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis.
Chen WC; Chen NJ; Chen HP; Yu WK; Su VY; Chen H; Wu HH; Yang KY
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630825
[TBL] [Abstract][Full Text] [Related]
31. Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.
Zhao XK; Cheng Y; Liang Cheng M; Yu L; Mu M; Li H; Liu Y; Zhang B; Yao Y; Guo H; Wang R; Zhang Q
Sci Rep; 2016 Jan; 6():19276. PubMed ID: 26763945
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing.
García-de-Alba C; Becerril C; Ruiz V; González Y; Reyes S; García-Alvarez J; Selman M; Pardo A
Am J Respir Crit Care Med; 2010 Nov; 182(9):1144-52. PubMed ID: 20622038
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy.
Kasam RK; Reddy GB; Jegga AG; Madala SK
Front Pharmacol; 2019; 10():532. PubMed ID: 31156440
[TBL] [Abstract][Full Text] [Related]
34. Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.
De Biasi S; Cerri S; Bianchini E; Gibellini L; Persiani E; Montanari G; Luppi F; Carbonelli CM; Zucchi L; Bocchino M; Zamparelli AS; Vancheri C; Sgalla G; Richeldi L; Cossarizza A
BMC Med; 2015 Nov; 13():277. PubMed ID: 26552487
[TBL] [Abstract][Full Text] [Related]
35. Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytes.
Sato S; Chong SG; Upagupta C; Yanagihara T; Saito T; Shimbori C; Bellaye PS; Nishioka Y; Kolb MR
Thorax; 2021 Sep; 76(9):895-906. PubMed ID: 33859055
[TBL] [Abstract][Full Text] [Related]
36. Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects.
García de Alba C; Buendia-Roldán I; Salgado A; Becerril C; Ramírez R; González Y; Checa M; Navarro C; Ruiz V; Pardo A; Selman M
Am J Respir Crit Care Med; 2015 Feb; 191(4):427-36. PubMed ID: 25531246
[TBL] [Abstract][Full Text] [Related]
37. Nintedanib (BIBF 1120) blocks the tumor promoting signals of lung fibroblast soluble microenvironment.
Epstein Shochet G; Israeli-Shani L; Koslow M; Shitrit D
Lung Cancer; 2016 Jun; 96():7-14. PubMed ID: 27133742
[TBL] [Abstract][Full Text] [Related]
38. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
Kimura T; Nojiri T; Hino J; Hosoda H; Miura K; Shintani Y; Inoue M; Zenitani M; Takabatake H; Miyazato M; Okumura M; Kangawa K
Respir Res; 2016 Feb; 17():19. PubMed ID: 26895702
[TBL] [Abstract][Full Text] [Related]
39. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells.
Li M; Ping G; Plathow C; Trinh T; Lipson KE; Hauser K; Krempien R; Debus J; Abdollahi A; Huber PE
BMC Cancer; 2006 Mar; 6():79. PubMed ID: 16556328
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib.
Epstein Shochet G; Brook E; Eyal O; Edelstein E; Shitrit D
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1025-L1034. PubMed ID: 30810067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
